Posts Tagged ‘patent expiration’

New patent expiration for Viiv Hlthcare drug RESCRIPTOR

Annual Drug Patent Expirations for RESCRIPTOR Rescriptor is a drug marketed by Viiv Hlthcare and is included in one NDA. It is available from one supplier. There is one patent…
The post New patent expiration for Viiv Hlthcare drug RESCRIPTOR appeared f…


Drug Patent Expirations for the Week of June 2, 2019

RESCRIPTOR (delavirdine mesylate) Viiv hlthcare Patent: 6,177,101 Expiration: Jun 7, 2019 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]
The post …


Patent delisted for Purdue Pharma drug OXYCONTIN

Annual Drug Patent Expirations for OXYCONTIN Oxycontin is a drug marketed by Purdue Pharma Lp and is included in one NDA. It is available from twelve suppliers. There are twenty…
The post Patent delisted for Purdue Pharma drug OXYCONTIN appeared first …


Patent delisted for Eli Lilly drug EFFIENT

Annual Drug Patent Expirations for EFFIENT Effient is a drug marketed by Eli Lilly And Co and is included in one NDA. It is available from one supplier. There are…
The post Patent delisted for Eli Lilly drug EFFIENT appeared first on DrugPatentWatch – …


Patent delisted for Teva Branded drug PROAIR DIGIHALER

Annual Drug Patent Expirations for PROAIR+DIGIHALER Proair Digihaler is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from two suppliers. There are…
The post Patent delisted for Teva Branded drug PROAIR DIGIHALER app…


Patent delisted for Teva Branded drug PROAIR RESPICLICK

Annual Drug Patent Expirations for PROAIR+RESPICLICK Proair Respiclick is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from two suppliers. There are…
The post Patent delisted for Teva Branded drug PROAIR RESPICLICK …


Patent delisted for Astellas drug LEXISCAN

Annual Drug Patent Expirations for LEXISCAN Lexiscan is a drug marketed by Astellas and is included in one NDA. It is available from one supplier. There are seventeen patents protecting…
The post Patent delisted for Astellas drug LEXISCAN appeared firs…


Drug Patent Expirations for the Week of May 26, 2019

RANEXA (ranolazine) Gilead Patent: 6,303,607 Expiration: May 27, 2019 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Patent…


New patent expiration for Pfizer Inc drug GEODON

Annual Drug Patent Expirations for GEODON Geodon is a drug marketed by Pfizer and Pfizer Inc and is included in three NDAs. It is available from seven suppliers. There are…
The post New patent expiration for Pfizer Inc drug GEODON appeared first on Dru…


New patent expiration for Gilead drug RANEXA

Annual Drug Patent Expirations for RANEXA Ranexa is a drug marketed by Gilead and is included in one NDA. It is available from three suppliers. There are ten patents protecting…
The post New patent expiration for Gilead drug RANEXA appeared first on Dr…


Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog